Duchenne Muscular Dystrophy joins newborn screening list—free tests incoming!
Published Date: 12/22/2025
Notice
Summary
Great news! Duchenne Muscular Dystrophy (DMD), a serious muscle disease affecting newborns, is now officially added to the list of conditions all babies should be screened for at birth. Starting one year after this announcement, health insurance plans must cover these screenings with no extra costs, helping families catch and treat DMD early for better outcomes.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Insurers must cover DMD newborn screening
The HHS Secretary added Duchenne Muscular Dystrophy (DMD) to the Recommended Uniform Screening Panel on December 16, 2025. Non-grandfathered group health plans and health insurance issuers must cover the DMD newborn screening without copayments, coinsurance, or deductibles for plan years beginning on or after December 16, 2026 (one year after the Secretary's adoption).
Earlier diagnosis enables treatment access
HRSA and commenters noted that adding DMD to the RUSP may let families receive a DMD diagnosis sooner, enabling earlier access to interventions, support services, and treatment options. The notice also states there are FDA-approved treatments that can help children walk longer and extend heart and lung functions.
State adoption not required immediately
Adding DMD to the RUSP does not force states to start screening right away. States still decide if and when to add DMD to their newborn screening programs based on their budgets and priorities.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06188 — Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Black Lung Clinics Program Performance Measures, OMB No. 0915-0292-Revision
HRSA is updating how Black Lung Clinics report their yearly progress to make things clearer and easier for them. This affects clinics helping coal miners with lung disease, and HRSA wants your thoughts before finalizing the changes. Comments are due by June 1, 2026, and the update aims to keep the program effective without adding extra hassle or cost.
2026-05663 — Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Rural Health Care Coordination Program Performance Improvement Measures, OMB No. 0906-0024-Revision
HRSA is updating how it collects info from rural health programs that fight heart disease, cancer, stroke, and more. They want your thoughts on making reporting easier and clearer before sending the changes to the budget office. If you’re involved in rural health care, now’s the time to speak up by May 26, 2026—no extra costs, just better data!
2026-05253 — Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Delta States Rural Development Network Grant Program, OMB No. 0915-0386-Revision
HRSA is updating how it collects info from groups funded by the Delta States Rural Development Network Grant Program, which helps fight heart disease, diabetes, stroke, and obesity in rural Delta communities. They want your thoughts on the changes before sending them to the budget office. If you’re involved or interested, get your comments in by May 18, 2026—this helps make sure the program runs smoothly and shows real health improvements.
2026-05274 — Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Countermeasures Injury Compensation Program-OMB No. 0915-0334-Revision
HRSA is updating the forms and questions for the Countermeasures Injury Compensation Program to make things easier and clearer for people filing claims. This affects anyone who might get injured by certain medical countermeasures, like vaccines or treatments during emergencies. The public can comment on these changes until April 17, 2026, and no new costs are expected.
2026-05133 — Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Ryan White HIV/AIDS Program: Allocations Report Forms, OMB No. 0915-0318-Revision
HRSA is updating the Ryan White HIV/AIDS Program report forms to make it easier for grant recipients to track and share how they use funds. This change helps reduce paperwork by using an electronic system that pre-fills data, saving time and effort. If you’re involved in this program, get ready to send your comments by April 16, 2026, as these updates keep the money flowing smoothly and on track.
2026-04900 — Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; The Maternal, Infant, and Early Childhood Home Visiting Program Performance Measurement Information System
HRSA is asking for public feedback on their plan to keep tracking how well the Maternal, Infant, and Early Childhood Home Visiting Program is doing. This program helps families in all 56 states, tribes, and territories by supporting home visits that improve early childhood health. Comments are open until April 13, 2026, and the info collected helps make sure the program stays effective without costing extra money.
Previous / Next Documents
Previous: 2025-23572 — Agency Information Collection Activities; Application for Permit To Modify (APM) and Supporting Documentation
The Bureau of Safety and Environmental Enforcement wants to keep collecting info for permits to modify offshore operations. This affects companies working in oil and gas who need to update their permits. They’re asking for public comments by February 20, 2026, to make sure the process stays smooth and doesn’t create extra paperwork or costs.
Next: 2025-23574 — Addition of Metachromatic Leukodystrophy to the Recommended Uniform Screening Panel
Great news for newborns and families! Metachromatic Leukodystrophy (MLD), a serious but treatable condition, is now officially added to the list of recommended newborn screenings. Starting soon, health plans must cover this screening with no extra cost, helping catch MLD early and save lives.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in